Disability services must include health screening, stress management for caregivers: Study
The study suggests providing parents or caregivers raising a child with developmental disabilities like autism, and attention deficit hyperactivity disorder (ADHD) with proper support systems for their well-being.
Published in the Asia Pacific Journal of Social Work and Development, the team investigated how the continuous demands of caregiving impact parent's physical health, ultimately affecting their overall quality of life.
The research showed that raising children with developmental disabilities presents unique and often lifelong challenges. It includes teaching basic self-care to manage behavioural and sensory difficulties, that can result in deep emotional exhaustion and physical symptoms such as headaches, ulcers, chronic pain, and fatigue, particularly among mothers.
Importantly, the study found that while physical health partly explains how stress affects parents' health, it does not account for challenges such as financial strain.
The researchers recommended integrating caregiver health screening and stress management into paediatric disability services.
They also advocate for community-based 'one-stop' support centres where families can access medical, mental health, and financial support in one place.
'Disability rights are rightly acknowledged, yet the invaluable contributions of caregivers often remain in the shadows. Caring for a child with developmental disabilities should not rest solely on parents, it is a shared responsibility of family, neighbours, and society,' said Dr. Ramakrishna Biswal, Associate Professor, Department of Humanities and Social Sciences, NIT Rourkela.
The team surveyed 400 parents of children with conditions like autism, ADHD, cerebral palsy, and multiple disabilities.
In India, these challenges are often intensified by social stigma, lack of awareness, and limited access to specialised care.
Many parents feel isolated from their communities and are unable to receive support from extended family. Healthcare, therapy, and respite services remain limited in many regions.
"Caregiving is a demanding journey, but with non-judgmental support and wholehearted cooperation from trusted individuals and communities, caregivers can find strength, relief, and validation. Let us recognise their rights and ensure they, too, enjoy a life of dignity and fulfillment," Biswal said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
a day ago
- India Today
Paracetamol during pregnancy linked to high risk of autism and ADHD in babies
Taking paracetamol during pregnancy, one of the most common medicines used for fever and pain, may increase the risk of certain neurodevelopmental disorders in newborns, including autism and ADHD (attention-deficit/hyperactivity disorder), according to new also known globally as acetaminophen and sold under popular brands such as Crocin or Dolo, is used by more than half of pregnant women worldwide. It has long been considered safe compared to other painkillers, but scientists are now questioning this THE STUDY FOUND Researchers from the University of Massachusetts, Harvard University, and Institute for Health Equity Research reviewed decades of scientific evidence to understand the link between acetaminophen use during pregnancy and child the study published in Environmental Health, they examined 46 studies and found that 27 studies reported a link between prenatal paracetamol use and conditions such as autism, ADHD, or other neurodevelopmental disorders (NDDs).While 9 studies found no association, 4 studies suggested a protective effect, though these were less the stronger, higher-quality studies were more likely to show a positive link, strengthening the ARE THESE DISORDERS?Autism spectrum disorder (ASD): A developmental condition that affects social interaction, communication, and behaviour. Symptoms can range from mild to (attention-deficit/hyperactivity disorder): A condition where children may struggle with focus, controlling impulses, or staying disorders (NDDs): A broader group of conditions that affect how the brain grows and functions, leading to learning, behavioural, or communication THIS MATTERSThe findings are worrying because paracetamol is usually the first medicine doctors recommend during pregnancy when a woman has fever, headaches, or body pain. Unlike stronger drugs such as ibuprofen or aspirin, which are generally avoided in pregnancy, paracetamol has been considered the 'safer' choice for decades.'Our analyses support evidence consistent with an association between acetaminophen exposure during pregnancy and increased incidence of neurodevelopmental disorders. Appropriate and immediate steps should be taken to advise pregnant women to limit acetaminophen consumption to protect their offspring's neurodevelopment," the researchers PREGNANT WOMEN BE WORRIED?While the findings do not say that women should never take paracetamol, but caution is needed. Untreated fever or severe pain in pregnancy can also harm both the mother and baby, so a balance must be paracetamol only when absolutely the lowest effective dose for the shortest possible consult a doctor before taking any medicine during pregnancy, even common over-the-counter research is needed to confirm exactly how strong the link is, but pregnant women should be cautious and avoid safest advice: don't panic, but always check with your doctor before reaching for that Crocin.- EndsMust Watch
Time of India
2 days ago
- Time of India
For people with ADHD, medication can reduce risk of accidents, crime, suicide
Sydney: Attention-deficit hyperactivity disorder ( ADHD ) is a neurodevelopmental condition that affects around 7 per cent of children and 2.5 per cent of adults. ADHD causes difficulties with holding and sustaining attention over periods of time. People with ADHD also experience hyperactivity and high levels of impulsiveness and arousal. This can make it difficult to plan, coordinate and remain engaged in tasks. ADHD is linked to problems at work, school and home, and to higher rates of mental illnesses such as anxiety . It's also associated with higher rates of long-term harms. Stimulant medication , such as methylphenidate and dextroamphetamine, is the most common treatment for managing ADHD symptoms. Most people with ADHD will respond to at least one ADHD medication. But rising rates of prescriptions in recent years have prompted concern for their effectiveness and safety. New research published today in the journal BMJ points to additional longer-term benefits. It found that people with ADHD who took medication were less likely to have suicidal behaviours, transport accidents , issues with substance misuse, or be convicted of a crime. What did the study do? The study tracked 148,581 people who received a new diagnosis of ADHD between 2007 and 2018. The authors used population-based data from Swedish national registers, including everyone aged six to 64 who was newly diagnosed with ADHD. The average age was 17.4 years, and 41per cent were female. Participants either started or did not start medication within three months of their ADHD diagnosis. The authors examined the effects of drug treatment for ADHD on five critical outcomes: suicidal behaviours, substance misuse, accidental injuries, transport accidents and committing crimes. They looked at both first-time and recurrent events. This study used a method that uses data from health records or registries to mimic the design of a randomised controlled trial, in an attempt to reduce bias. The researchers accounted for age, education, other mental and physical illnesses, prior history and use of other drugs to account for factors that may influence results. What did they find? Within three months of receiving an ADHD diagnosis, 84,282 (56.7 per cent) of people had started drug treatment for ADHD. Methylphenidate was the most commonly prescribed drug, accounting for 88.4 per cent of prescriptions. Drug treatment for ADHD was associated with reduced rates of a first occurrence for four out of the five outcomes: a 17 per cent reduction for suicidal behaviours, 15 per cent for substance misuse, 12 per cent for transport accidents and 13 per cent for committing a crime. When the researchers looked at people with recurrent events, the rate reductions associated with ADHD medication were seen for all five outcomes (including accidental injury). The effect of medication was particularly strong when someone had a history of these events happening frequently. This means those with the most severe symptoms may benefit most. Stimulant drugs were associated with lower rates of all five outcomes compared with non-stimulant drugs. It's likely these benefits are associated with improvements in attention, impulsivity and hyperactivity. People may be less likely to be distracted while driving, to self-medicate and show impacts from other mental health challenges. What didn't the study do? The large sample size, use of national linked registers and sophisticated design give greater confidence that these findings are due to medication use and not due to other factors. But the study was not able to examine medication dosages or track whether people reliably took their medication as prescribed. It also had no way to track the severity of ADHD symptoms. This means it can't tell us if this helped most people or just some people with severe symptoms. We know that ADHD medication helps most people, but it is not effective for everyone. So, we still need to understand why some people don't benefit from ADHD medication, and what other treatments might also be helpful. Finally, even though the study was rigorous in its design and adjusted for many factors, we can't rule out that other unaccounted factors could be associated with these effects. As prescribing increases, the size of the benefit decreases. A second study, published in June, used the same Swedish national registers and self-controlled case series design. This study also concluded that ADHD medication was associated with reduced risks for self-harm, accidental injuries, transport accidents and committing a crime. However, this study also showed that as prescribing rates increased nearly fivefold between 2006 and 2020, the size of the observed benefits of ADHD medications reduced. While remaining significant, the size of the associations between ADHD medication use and lower risks of unintentional injury, traffic crashes, and crime weakened over this time. This could mean people who are less likely to need ADHD medications are now receiving them. What are the impacts for patients and policymakers? People need to know that if ADHD medications are helpful for them or their children, they might also improve many other areas of life. These findings can also give governments confidence that their recent initiatives and efforts to increase access to ADHD support and treatment may have positive downstream impacts on broader social outcomes. But medications aren't the only ADHD treatment. Medication should only represent one part of a solution, with other psychological supports for managing emotional regulation, executive and organisational skills and problem-solving also beneficial. Psychological therapies are effective and can be used in combination with, or separately from, medication. Yet research shows drug treatments are relied on more frequently in more disadvantaged communities, where it's harder to access psychological supports. Policymakers need to ensure medication does not become the only treatment people have access to. People with suspected ADHD need a high-quality diagnostic assessment to ensure they get the right diagnosis and the treatment most suitable for them. (The Conversation)
Hans India
2 days ago
- Hans India
Study warns paracetamol may not be safe during pregnancy
Paracetamol, also known as acetaminophen, has long been regarded as the safest and most widely used painkiller during pregnancy. However, a new study suggests its use may be associated with an increased risk of neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD), in children. The research, conducted by scientists from the University of Massachusetts and Harvard University, analyzed 46 studies covering data from over 100,000 individuals. Of these, 27 studies reported significant associations between prenatal acetaminophen exposure and developmental challenges. 'The majority of the studies reported positive associations of prenatal acetaminophen use with ADHD, ASD, or NDDs in offspring,' said Andrea A. Baccarelli of the Harvard T.H. Chan School of Public Health, the study's corresponding author. Researchers noted that acetaminophen can cross the placental barrier, potentially leading to oxidative stress, hormonal disruptions, and epigenetic changes — all of which may interfere with foetal brain development. Previous studies have also raised concerns. A 2017 report linked prolonged acetaminophen use (22–28 days) in pregnancy with higher ADHD risk, while a study published earlier this year suggested increased ADHD odds in girls exposed to the drug in utero. While acetaminophen remains the preferred pain relief option due to its relatively favorable safety profile compared to alternatives, experts advise cautious use. 'Appropriate and immediate steps should be taken to advise pregnant women to limit acetaminophen consumption to protect their offspring's neurodevelopment,' Baccarelli said, while calling for further large-scale research to confirm the risks.
